Replies to post #895 on Harvard Apparatus Regenerative Tech Inc. (HRGN)

[sci101]

According to the presentations, the pre-clinical data is very positive, including from large animal models. The FDA seems to agree with that assessment since they gave them the ODD after the meeting.

Details are going to be published Q42016 - Q12017 (Mayo Clinic).